Crown Holdings Inc. logo

Crown Holdings Inc. (CCK)

Market Open
12 Dec, 15:31
NYSE NYSE
$
96. 98
+1.03
+1.08%
$
11.28B Market Cap
21.19 P/E Ratio
1% Div Yield
89,741 Volume
6.04 Eps
$ 95.95
Previous Close
Day Range
95.68 97.19
Year Range
75.98 109.48
Want to track CCK and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 54 days
Crown Castle Stock: A Golden Opportunity Near 52-Week Lows For Long-Term Investors

Crown Castle Stock: A Golden Opportunity Near 52-Week Lows For Long-Term Investors

Crown Castle (CCI) stock is trading near 52-week lows, presenting an attractive entry point for long-term investors with a robust 6.45% dividend yield. CCI's strategic focus on small cells and 5G infrastructure positions it for significant long-term growth, despite current macroeconomic challenges and high capex demands. The company's optimization efforts, including cost-cutting and asset prioritization, have bolstered its financial performance, with impressive profitability metrics and a strong balance sheet.

Seekingalpha | 0 year ago
Is the Options Market Predicting a Spike in Crown Holdings (CCK) Stock?

Is the Options Market Predicting a Spike in Crown Holdings (CCK) Stock?

Investors need to pay close attention to Crown Holdings (CCK) stock based on the movements in the options market lately.

Zacks | 1 year ago
Is Crown Holdings (CCK) a Great Value Stock Right Now?

Is Crown Holdings (CCK) a Great Value Stock Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Zacks | 1 year ago
Revance agrees to lower-priced buyout offer by Crown Laboratories

Revance agrees to lower-priced buyout offer by Crown Laboratories

Anti-wrinkle injection maker Revance Therapeutics has agreed to be bought for $3.10 per share by privately held Crown Laboratories, instead of $6.66 per share agreed previously, the two companies said on Monday.

Reuters | 1 year ago
Why Crown Holdings (CCK) is a Top Value Stock for the Long-Term

Why Crown Holdings (CCK) is a Top Value Stock for the Long-Term

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Zacks | 1 year ago
Crown Castle: Analyzing Historical And Future Fair Value

Crown Castle: Analyzing Historical And Future Fair Value

Crown Castle Inc (CCI) is trading at 15% above its 52-week low, offering a 39% upside based on historical fair value metrics. Using a dividend discount model, CCI's fair value is estimated at $146, implying a 37% upside potential. Despite concerns about the Fiber segment, Q3 results show revenue growth and a commitment to improve profitability.

Seekingalpha | 1 year ago
Crown Castle: Buy The Dip Hand Over Fist

Crown Castle: Buy The Dip Hand Over Fist

Crown Castle Inc. presents a compelling buy-the-dip opportunity with a high dividend yield of 6.1% and a historically low valuation. CCI's strong Q3 performance, driven by robust growth in small cells and fiber solutions, underscores its resilience amidst economic uncertainties. The company's strategic focus on co-location over new builds is expected to enhance capital efficiency and support long-term growth.

Seekingalpha | 1 year ago
Should Value Investors Buy Crown Holdings (CCK) Stock?

Should Value Investors Buy Crown Holdings (CCK) Stock?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Zacks | 1 year ago
My 6.3% Yielding Crown Jewel: Why Antero Midstream Remains A Strong Buy

My 6.3% Yielding Crown Jewel: Why Antero Midstream Remains A Strong Buy

Antero Midstream, my highest-yielding dividend stock, plays a crucial role in my portfolio. It accounts for over 14% of my dividend income and remains a top conviction pick. Despite past challenges and a dividend cut in 2021, Antero Midstream has rebounded strongly. The company reduced debt and leveraged its relationship with Antero Resources. With its 6.3% yield and improved fundamentals, Antero Midstream is poised for continued growth.

Seekingalpha | 1 year ago
Is the Options Market Predicting a Spike in Crown Holdings (CCK) Stock?

Is the Options Market Predicting a Spike in Crown Holdings (CCK) Stock?

Investors need to pay close attention to Crown Holdings (CCK) stock based on the movements in the options market lately.

Zacks | 1 year ago
Crown Castle Is Still A Better Play Than American Tower

Crown Castle Is Still A Better Play Than American Tower

American Tower Corporation's international growth and asset sales have improved its relative position, but Crown Castle Inc. remains a strong buy due to its upside potential. Crown Castle has faced revenue and profit declines, largely due to Sprint cancellations, but remains a cash cow with potential asset sales as a growth catalyst. American Tower has shown consistent growth and better profit margins, making it a solid buy, though it is pricier than Crown Castle.

Seekingalpha | 1 year ago
Crown Castle: Paving The Way For AI-Backed Dividends

Crown Castle: Paving The Way For AI-Backed Dividends

Crown Castle remains a solid investment with a 5.6% yield, covered by earnings, despite slower growth and operational challenges. CCI's valuation has improved, and it is well-positioned to capitalize on 5G deployment and increasing data transport demand. The company's strong fundamentals, high forecast accuracy, and significant infrastructure assets make it a low-risk investment with potential for 17.5% annualized returns.

Seekingalpha | 1 year ago
Loading...
Load More